Profile of Fraunhofer ITEM

Headed by the institute director, Fraunhofer ITEM is organized in six divisions. The institute‘s headquarters with most of its divisions are in Hannover (Germany), except for the Division of Pharmaceutical Biotechnology, which has its facilities in Braunschweig on the Science Campus Braunschweig-Süd, and the Division of Personalized Tumor Therapy, which is based in Regensburg‘s BioPark. The Fraunhofer ITEM Division of Personalized Tumor Therapy was set up as a joint initiative of Fraunhofer ITEM, the Fraunhofer-Gesellschaft, and the University of Regensburg.

At the end of 2019, 383 people were employed at Fraunhofer ITEM. The institute's sponsors include industry and commercial associations, the public sector, and the EU. The institute's budget in 2019 reached a level of approximately 31 million euros. Financing by acquired funding amounted to 69 percent. The share of industrial income in the institute’s budget was 46 percent. Investments of Fraunhofer ITEM amounted to approximately 3.4 million euros. For more details, please click on the below figures (as of March 2020).